-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Evoke Pharma Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2023.
- Evoke Pharma Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$43.7K, a 47.7% increase year-over-year.
- Evoke Pharma Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$312K, a 14.7% increase year-over-year.
- Evoke Pharma Inc annual Nonoperating Income (Expense) for 2023 was -$361K, a 17.5% increase from 2022.
- Evoke Pharma Inc annual Nonoperating Income (Expense) for 2022 was -$438K, a 13.4% decline from 2021.
- Evoke Pharma Inc annual Nonoperating Income (Expense) for 2021 was -$386K, a 260% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)